세계의 효소 보충 요법 시장(2025년)

Enzyme Replacement Therapy Global Market Report 2025

US $ 4,490 ￦ 6,265,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,056,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,846,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 효소 보충 요법 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 시장은 CAGR 9.3%로 확대되고 2029년에는 178억 1,000만 달러로 성장할 것으로 예측됩니다. 예측 기간의 성장은 건강 관리에 대한 환자 접근 증가, 맞춤형 치료 및 맞춤형 의료, 규제 상황의 변화, 환자 집단의 의식 증가로 인한 것으로 예상됩니다. 예측 기간의 주요 동향으로는 디지털 건강 통합, 환자 중심 솔루션에 대한 주력, 새로운 바이오마커 연구, 정밀의료 접근 등이 있습니다.

희귀질환, 만성질환, 유전성질환의 유병률 상승은 향후 수년간 효소 보충 요법 시장의 성장을 가속할 것으로 예상됩니다. 만성 질환은 3개월 이상 지속되고 시간이 지남에 따라 악화될 수 있는 질병으로 정의됩니다. 이러한 질병은 노인에게 많으며 일반적으로 관리는 가능하지만 치유는 불가능합니다. 예를 들어 미국에 본사를 둔 비영리 단체인 미국 폐협회는 2024년 7월, 2022년에는 4,420만 명의 미국인(인구의 13.5%)이 의료기관에서 천식으로 진단되어 2021년의 12.9%에서 증가했다고 보고했습니다. 따라서 희귀질환, 만성 질환 및 유전성 질환의 유병률 증가는 효소 보충 요법 시장의 성장을 가속할 것으로 예상됩니다.

건강 관리 지출 증가는 미래의 효소 보충 요법(ERT) 시장의 성장을 가속할 것으로 예측됩니다. 헬스케어 지출은 일정 기간 동안 헬스케어 시스템 또는 경제권 내의 헬스케어 서비스, 물품, 활동에 할당되는 총 자금입니다. 이 지출은 연구, 개발, 임상시험, 검사 등 고도로 전문화되고 고액이 되기 쉬운 ERT의 치료를 지원하는 것입니다. 예를 들어, 2022년 12월 미국에 본사를 둔 연방 기관인 Centers for Medicare & Medicaid Services는 미국 의료 지출이 2022년에 4.1% 증가한 4조 5,000억 달러에 이르렀고 2021년 3.2% 증가를 초과했다고 보고했습니다. 따라서 의료비 증가는 효소 보충 요법 시장의 성장을 뒷받침하고 있습니다.

본 보고서는 세계의 효소 보충 요법 시장에 대해 조사했으며, 시장 개요와 함께 효소 유형별, 투여 경로별, 용도별 최종 사용자별, 지역·국가별 동향 및 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 주요 요약

제2장 효소 보충 요법 시장 특징

제3장 효소 보충 요법 시장 동향과 전략

제4장 효소 보충 요법 시장-금리, 인플레이션, 지정학, COVID-19의 영향과 회복을 포함한 거시경제 시나리오

제5장 효소 보충 요법의 세계 성장 분석과 전략 분석 프레임워크

• PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
• 최종 이용 산업의 분석
• 세계의 효소 보충 요법 시장의 성장률 분석
• 세계의 효소 보충 요법 시장 규모 실적과 성장, 2019-2024년
• 세계의 효소 보충 요법 시장 규모와 성장 예측, 2024-2029년, 2034년 예상
• 세계 효소 보충 요법 유효 시장 규모(TAM)

제6장 효소 보충 요법 시장 세분화

• 세계의 효소 보충 요법 시장, 효소 유형별 세분화, 분석 및 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 효소 보충 요법 시장, 투여 경로별 세분화, 분석 및 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 효소 보충 요법 시장, 용도별 세분화, 분석 및 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 효소 보충 요법 시장, 최종 사용자별 세분화, 분석 및 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 효소 보충 요법 시장, 아가르시다아제 알파의 서브 세분화, 유형별, 분석 및 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 효소 보충 요법 시장, 아가르시다아제 베타의 서브 세분화, 유형별, 분석 및 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 효소 보충 요법 시장, 갈설파아제의 서브 세분화, 유형별, 분석 및 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 효소 보충 요법 시장, 기타 서브 세분화, 유형별, 분석 및 예측, 2019-2024년, 2024-2029년, 2034년

제7장 효소 보충 요법 시장의 지역별 및 국가별 분석

• 세계의 효소 보충 요법 시장, 지역별, 분석 및 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 효소 보충 요법 시장, 국가별, 분석 및 예측, 2019-2024년, 2024-2029년 예측, 2034년 예측

제8장 아시아태평양의 효소 보충 요법 시장

제9장 중국의 효소 보충 요법 시장

제10장 인도의 효소 보충 요법 시장

제11장 일본의 효소 보충 요법 시장

제12장 호주 효소 보충 요법 시장

제13장 인도네시아의 효소 보충 요법 시장

제14장 한국의 효소 보충 요법 시장

제15장 서유럽의 효소 보충 요법 시장

제16장 영국의 효소 보충 요법 시장

제17장 독일의 효소 보충 요법 시장

제18장 프랑스의 효소 보충 요법 시장

제19장 이탈리아의 효소 보충 요법 시장

제20장 스페인의 효소 보충 요법 시장

제21장 동유럽의 효소 보충 요법 시장

제22장 러시아의 효소 보충 요법 시장

제23장 북미의 효소 보충 요법 시장

제24장 미국의 효소 보충 요법 시장

제25장 캐나다의 효소 보충 요법 시장

제26장 남미의 효소 보충 요법 시장

제27장 브라질 효소 보충 요법 시장

제28장 중동의 효소 보충 요법 시장

제29장 아프리카의 효소 보충 요법 시장

제30장 효소 보충 요법 시장 경쟁 구도와 기업 프로파일

• 효소 보충 요법 시장 경쟁 구도
• 효소 보충 요법 시장 기업 프로파일
  • Biomarin Pharmaceutical Inc.
  • Leadiant Biosciences Inc.
  • Pfizer Inc.
  • Sanofi SA
  • AbbVie Inc.

제31장 기타 선도적이고 혁신적인 기업

• Johnson & Johnson Services Inc.
• Alexion Pharmaceuticals Inc.
• Recordati Rare Diseases Inc.
• Sangamo Therapeutics Inc.
• JCR Pharmaceuticals Co. Ltd.
• Horizon Pharma Public Limited Company
• Protalix Biotherapeutics Ltd.
• Amicus Therapeutics Inc.
• AstraZeneca plc
• Novartis AG
• Roche Holding AG
• GlaxoSmithKline plc
• Merck & Co. Inc.
• Eli Lilly and Company
• Bristol-Myers Squibb Company

제32장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 동향

제35장 잠재성이 높은 국가, 부문, 전략

제36장 부록

JHS

영문 목차

영문목차

Enzyme replacement therapy (ERT) refers to a sort of medical treatment in which patients with chronic disorders brought on by insufficient or failing enzymes are given alternative enzymes. The body can complete the processes inhibited by the deficit by getting enzyme replacements. It is particularly effective at returning urinary GAG levels to normal and boosting liver and spleen development.

The main types of enzymes used in enzyme replacement therapy include agalsidase alfa, agalsidase beta, galsulfase, other enzyme types that are used in gaucher disease, pompe disease, fabry disease, others. Agalsidase alfa refers to a recombinant human alpha-galactosidase that is used in the treatment of fabry's disease as an enzyme replacement therapy. It has a long half-life and a broad therapeutic spectrum. Patients should be advised about the possibility of infusion-related symptoms and sensitivity. Agalsidase alfa is beneficial to enzyme replacement therapy because it aids in the treatment of Fabry disease. The enzyme replacement therapy is used by hospitals, infusion centers and others that is administered through oral and parenteral route.

The enzyme replacement therapy market research report is one of a series of new reports from The Business Research Company that provides enzyme replacement therapy market statistics, including enzyme replacement therapy industry global market size, regional shares, competitors with enzyme replacement therapy market share, detailed enzyme replacement therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the enzyme replacement therapy industry. This enzyme replacement therapy market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry

The enzyme replacement therapy market size has grown strongly in recent years. It will grow from$11.58 billion in 2024 to $12.48 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to growing early therapeutic discoveries, pioneering treatment approvals, expanded disease understanding, clinical success stories, regulatory support and incentives

The enzyme replacement therapy market size is expected to see strong growth in the next few years. It will grow to $17.81 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing patient access to healthcare, tailored therapies and personalized medicine, regulatory landscape changes, and growing patient population awareness. Major trends in the forecast period include digital health integration, focus on patient-centric solutions, emerging biomarker research, and precision medicine approach.

The increasing prevalence of rare, chronic, and inherited disorders is anticipated to drive the growth of the enzyme replacement therapy market in the coming years. Chronic disease is defined as an illness lasting three months or more that may worsen over time. Such diseases are more prevalent among the elderly and are typically manageable but not curable. For example, in July 2024, the American Lung Association, a U.S.-based non-profit organization, reported that in 2022, 44.2 million Americans (or 13.5% of the population) had been diagnosed with asthma by a healthcare provider, up from 12.9% in 2021. Thus, the rising prevalence of rare, chronic, and inherited disorders is expected to fuel growth in the enzyme replacement therapy market.

The increase in healthcare spending is projected to drive the growth of the enzyme replacement therapy (ERT) market in the future. Healthcare expenditure represents the total funds allocated to healthcare services, goods, and activities within a healthcare system or economy over a given period. This spending supports ERT due to the highly specialized and often costly nature of these treatments, covering research, development, clinical trials, and testing. For example, in December 2022, the U.S.-based federal agency Centers for Medicare & Medicaid Services reported that U.S. healthcare spending grew by 4.1% to reach $4.5 trillion in 2022, outpacing the 3.2% growth in 2021. Thus, rising healthcare expenditures are fueling the growth of the enzyme replacement therapy market.

Product approvals have become a prominent trend gaining traction in the enzyme replacement therapy market. Various enzyme replacement therapy medications introduced by major players are securing approvals in the market. For example, in February 2023, Lamzede (velmanase alfa) received approval from the Food and Drug Administration, a US-based federal agency of the Department of Health. Lamzede is the first enzyme replacement therapy sanctioned in the United States for treating non-central neurological indications of alpha-mannosidosis, a rare genetic disorder characterized by the absence of the alpha-mannosidase enzyme. Administered as a 10mg injection once a week, Lamzede aids patients in regaining normal cellular function by mimicking the action of the alpha-mannosidase enzyme, thereby restoring healthy cellular functioning.

Major companies in the enzyme replacement therapy (ERT) market are strategically focusing on innovative treatment products and obtaining approvals for Pompe disease therapy to address the unmet medical needs of patients with late-onset Pompe disease. In response to the pressing medical needs for late-onset Pompe disease patients in the European Union, Amicus Therapeutics, a US-based biotechnology company, secured approval and launched a new Pompe disease therapy in June 2023. The treatment, comprising Pombiliti (cipaglucosidase alfa) and Opfolda (miglustat), serves as an enzyme replacement therapy for adults with late-onset Pompe disease, supported by clinical data and driven by potential market opportunities and regulatory backing.

In July 2024, Crosswalk Therapeutics Inc., a biotechnology company based in the United States, acquired Codexis Inc. for an undisclosed sum. This acquisition allows Crosswalk Therapeutics to broaden its expertise, integrating Codexis's advanced enzyme engineering technology into its offerings. Codexis Inc. is a U.S.-based company specializing in enzyme engineering.

Major companies operating in the enzyme replacement therapy market include Biomarin Pharmaceutical Inc., Leadiant Biosciences Inc., Pfizer Inc., Sanofi S.A., AbbVie Inc., Johnson & Johnson Services Inc., Alexion Pharmaceuticals Inc., Recordati Rare Diseases Inc., Sangamo Therapeutics Inc., JCR Pharmaceuticals Co. Ltd., Horizon Pharma Public Limited Company, Protalix Biotherapeutics Ltd., Amicus Therapeutics Inc., AstraZeneca plc, Novartis AG, Roche Holding AG, GlaxoSmithKline plc, Merck & Co. Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Retrophin Inc., Abeona Therapeutics Inc., Orchard Therapeutics plc, Ultragenyx Pharmaceutical Inc.

North America was the largest region in the enzyme replacement therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global enzyme replacement therapy market report during the forecast period. The regions covered in the enzyme replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the enzyme replacement therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The enzyme replacement therapy market includes revenues earned by entities by providing Sebelipase alfa, Elosulfase alfa, Idursulfase, AL glucosidase alfa and Alpha1-Proteinase inhibitor enzyme replacement therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Enzyme Replacement Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on enzyme replacement therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for enzyme replacement therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The enzyme replacement therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Enzyme Type: Agalsidase Alfa; Agalsidase Beta; Galsulfase; Other Enzyme Types
• 2) By Route Of Administration: Oral; Parenteral
• 3) By Application: Gaucher Disease; Pompe Disease; Fabry Disease; Other Applications
• 4) By End-Users: Hospitals; Infusion Centers; Other End-Users
• Subsegments:
• 1) By Agalsidase Alfa: Fabry Disease Treatment
• 2) By Agalsidase Beta: Fabry Disease Treatment
• 3) By Galsulfase: Mucopolysaccharidosis VI (MPS VI) Treatment
• 4) By Other Enzyme Types: Alglucosidase Alfa; Idursulfase; Velaglucerase Alfa
• Companies Mentioned: Biomarin Pharmaceutical Inc.; Leadiant Biosciences Inc.; Pfizer Inc.; Sanofi S.A.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Enzyme Replacement Therapy Market Characteristics

3. Enzyme Replacement Therapy Market Trends And Strategies

4. Enzyme Replacement Therapy Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Enzyme Replacement Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Enzyme Replacement Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Enzyme Replacement Therapy Market Growth Rate Analysis
• 5.4. Global Enzyme Replacement Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Enzyme Replacement Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Enzyme Replacement Therapy Total Addressable Market (TAM)

6. Enzyme Replacement Therapy Market Segmentation

• 6.1. Global Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Agalsidase Alfa
• Agalsidase Beta
• Galsulfase
• Other Enzyme Types
• 6.2. Global Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• 6.3. Global Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gaucher Disease
• Pompe Disease
• Fabry Disease
• Other Applications
• 6.4. Global Enzyme Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Infusion Centers
• Other End-Users
• 6.5. Global Enzyme Replacement Therapy Market, Sub-Segmentation Of Agalsidase Alfa, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fabry Disease Treatment
• 6.6. Global Enzyme Replacement Therapy Market, Sub-Segmentation Of Agalsidase Beta, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fabry Disease Treatment
• 6.7. Global Enzyme Replacement Therapy Market, Sub-Segmentation Of Galsulfase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mucopolysaccharidosis VI (MPS VI) Treatment
• 6.8. Global Enzyme Replacement Therapy Market, Sub-Segmentation Of Other Enzyme Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alglucosidase Alfa
• Idursulfase
• Velaglucerase Alfa

7. Enzyme Replacement Therapy Market Regional And Country Analysis

• 7.1. Global Enzyme Replacement Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Enzyme Replacement Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Enzyme Replacement Therapy Market

• 8.1. Asia-Pacific Enzyme Replacement Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Enzyme Replacement Therapy Market

• 9.1. China Enzyme Replacement Therapy Market Overview
• 9.2. China Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Enzyme Replacement Therapy Market

• 10.1. India Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Enzyme Replacement Therapy Market

• 11.1. Japan Enzyme Replacement Therapy Market Overview
• 11.2. Japan Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Enzyme Replacement Therapy Market

• 12.1. Australia Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Enzyme Replacement Therapy Market

• 13.1. Indonesia Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Enzyme Replacement Therapy Market

• 14.1. South Korea Enzyme Replacement Therapy Market Overview
• 14.2. South Korea Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Enzyme Replacement Therapy Market

• 15.1. Western Europe Enzyme Replacement Therapy Market Overview
• 15.2. Western Europe Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Enzyme Replacement Therapy Market

• 16.1. UK Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Enzyme Replacement Therapy Market

• 17.1. Germany Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Enzyme Replacement Therapy Market

• 18.1. France Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Enzyme Replacement Therapy Market

• 19.1. Italy Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Enzyme Replacement Therapy Market

• 20.1. Spain Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Enzyme Replacement Therapy Market

• 21.1. Eastern Europe Enzyme Replacement Therapy Market Overview
• 21.2. Eastern Europe Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Enzyme Replacement Therapy Market

• 22.1. Russia Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Enzyme Replacement Therapy Market

• 23.1. North America Enzyme Replacement Therapy Market Overview
• 23.2. North America Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Enzyme Replacement Therapy Market

• 24.1. USA Enzyme Replacement Therapy Market Overview
• 24.2. USA Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Enzyme Replacement Therapy Market

• 25.1. Canada Enzyme Replacement Therapy Market Overview
• 25.2. Canada Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Enzyme Replacement Therapy Market

• 26.1. South America Enzyme Replacement Therapy Market Overview
• 26.2. South America Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Enzyme Replacement Therapy Market

• 27.1. Brazil Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Enzyme Replacement Therapy Market

• 28.1. Middle East Enzyme Replacement Therapy Market Overview
• 28.2. Middle East Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Enzyme Replacement Therapy Market

• 29.1. Africa Enzyme Replacement Therapy Market Overview
• 29.2. Africa Enzyme Replacement Therapy Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Enzyme Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Enzyme Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Enzyme Replacement Therapy Market Competitive Landscape And Company Profiles

• 30.1. Enzyme Replacement Therapy Market Competitive Landscape
• 30.2. Enzyme Replacement Therapy Market Company Profiles
  • 30.2.1. Biomarin Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Leadiant Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Enzyme Replacement Therapy Market Other Major And Innovative Companies

• 31.1. Johnson & Johnson Services Inc.
• 31.2. Alexion Pharmaceuticals Inc.
• 31.3. Recordati Rare Diseases Inc.
• 31.4. Sangamo Therapeutics Inc.
• 31.5. JCR Pharmaceuticals Co. Ltd.
• 31.6. Horizon Pharma Public Limited Company
• 31.7. Protalix Biotherapeutics Ltd.
• 31.8. Amicus Therapeutics Inc.
• 31.9. AstraZeneca plc
• 31.10. Novartis AG
• 31.11. Roche Holding AG
• 31.12. GlaxoSmithKline plc
• 31.13. Merck & Co. Inc.
• 31.14. Eli Lilly and Company
• 31.15. Bristol-Myers Squibb Company

32. Global Enzyme Replacement Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Enzyme Replacement Therapy Market

34. Recent Developments In The Enzyme Replacement Therapy Market

35. Enzyme Replacement Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Enzyme Replacement Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Enzyme Replacement Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Enzyme Replacement Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료